TP53 and head and neck squamous cell carcinoma: Indeed, the mutational profile of TP53 has been recognized as an independent prognostic factor in HNSCC (30), which can stratify patients into low- and high-risk survival rates, the latter being the only group at a higher risk of treatment failure (31).